0 items USD 0.00Search
Your search for "hjresearch global t cell acute lymphoblastic leukemia treatment industry market research 2019" gave back 1596749 results.
Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Cell Division Cycle 7 Related Protein Kinase - Pipeline Review, H1 2020 Summary Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) –...
Catalog:
Global Markets Direct
May 2020
Price: USD 3,500.00
Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary According to the recently published report...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Drugs In Development, 2021 Summary According to the recently published report 'Histone...
Catalog:
Global Markets Direct
August 2021
Price: USD 3,500.00
Histone Deacetylase 1 - Pipeline Review, H2 2020 Summary Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) pipeline Target constitutes close to 38...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...
Catalog:
Global Markets Direct
April 2022
Price: USD 3,500.00
Erwinase is used in combination with other anti-neoplastic agents to treat acute lymphoblastic leukaemia. It may also be used in other neoplastic...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Wilms Tumor Protein - Pipeline...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Drugs in Development, 2021 Summary According to the recently published report...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) Drugs in Development by Stages, Target, MoA...
Catalog:
Global Markets Direct
October 2022
Price: USD 3,500.00
